Skip to content

    Cancer Health Center

    Font Size

    Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Clear Cell Sarcoma of the Kidney

    General Information About Clear Cell Sarcoma of the Kidney

    Clear cell sarcoma of the kidney is not a Wilms tumor variant, but it is an important primary renal tumor associated with a higher rate of relapse and death than favorable-histology (FH) Wilms tumor.[1] The classic pattern of clear cell sarcoma of the kidney is defined by nests or cords of cells separated by regularly spaced fibrovascular septa. In addition to pulmonary metastases, clear cell sarcoma also spreads to bone, brain, and soft tissue.[1] (Refer to the Wilms tumor Clinical Features and Diagnostic and Staging Evaluation sections of this summary for more information about the clinical features and diagnostic evaluation of childhood kidney tumors.)

    Recommended Related to Cancer


    This complementary and alternative medicine (CAM) information summary provides an overview of the use of hydrazine sulfate as a treatment for people with cancer. The summary includes a brief history of hydrazine sulfate research, results of clinical trials, and possible side effects of hydrazine sulfate use. This summary contains the following key information: Hydrazine sulfate is a chemical that has been studied as a treatment for cancer and as a treatment for the body wasting (i.e., cachexia)...

    Read the Overview article > >

    While little is known about the biology of clear cell sarcoma of the kidney, the t(10;17)(q22;p13) translocation has been reported. As a result of the translocation, the YWHAE-FAM22 fusion transcript is formed; this transcript was detected in 12% of cases of clear cell sarcoma of the kidney in one series. 17p13 is the site of the P53 gene; however, this gene does not show abnormal expression and most likely is not involved.[2] Gene expression studies revealed the upregulation of neural markers, with ensuing activation of the sonic hedgehog and Akt pathways.[3] When DNA methylation profiling was used, the epigenetic characteristics of clear cell sarcoma of the kidney, rhabdoid tumor of the kidney, and Ewing sarcoma of the kidney, in comparison with those of the non-neoplastic kidney, exhibited distinct DNA methylation profiles in a tumor type-specific manner. The DNA methylation pattern of the THBS1 CpG site is sufficient for distinction of clear cell sarcoma of the kidney from other pediatric renal tumors.[4]

    Younger age and stage IV disease have been identified as adverse prognostic factors for event-free survival (EFS).[5]

    Historically, relapses have occurred in long intervals after the completion of chemotherapy (up to 10 years); however, with current therapy, relapses after 3 years are uncommon.[6] The brain is a frequent site of recurrent disease, suggesting that it is a sanctuary site for cells that are protected from the intensive chemotherapy that patients currently receive.[5,7,8] An awareness of the clinical signs of recurrent disease in the brain is important during regular follow-up. There are no standard recommendations for the frequency of brain imaging during follow-up.

    1 | 2 | 3
    1 | 2 | 3
    Next Article:

    Today on WebMD

    man holding lung xray
    What you need to know.
    stem cells
    How they work for blood cancers.
    woman wearing pink ribbon
    Separate fact from fiction.
    Colorectal cancer cells
    Symptoms, screening tests, and more.
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas